Elevations of FosB in the nucleus accumbens during forced cocaine abstinence correlate with divergent changes in reward function

Neuroscience

Volumn 147, Issue 3, 2007, Pages 583-591

  Harris, G C ^a   Hummel, M ^a   Wimmer, M ^a   Mague, S D ^a   Aston Jones, G ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

anhedonia; basolateral amygdala; delta FosB; novelty; place conditioning; withdrawal

Indexed keywords

COCAINE; TRANSCRIPTION FACTOR FOSB;

AMYGDALOID NUCLEUS; ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DRUG DOSE ESCALATION; IMMUNOREACTIVITY; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; WITHDRAWAL SYNDROME;

ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; COCAINE; CONDITIONING, OPERANT; DOPAMINE UPTAKE INHIBITORS; GENE EXPRESSION REGULATION; MALE; NUCLEUS ACCUMBENS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; REWARD; SUBSTANCE WITHDRAWAL SYNDROME; SYSTOLE;

EID: 34250862594     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2007.04.050     Document Type: Article

References (57)

1. Andersson M., Westin J.E., and Cenci M.A. Time course of striatal DeltaFosB-like immunoreactivity and prodynorphin mRNA levels after discontinuation of chronic dopaminomimetic treatment. Eur J Neurosci 17 (2003) 661-666
2. Besheer J., and Bevins R.A. Impact of nicotine withdrawal on novelty reward and related behaviors. Behav Neurosci 117 (2003) 327-340
3. Besheer J., Jensen H.C., and Bevins R.A. Dopamine antagonism in a novel-object recognition and a novel-object place conditioning preparation with rats. Behav Brain Res 103 (1999) 35-44
4. Bevins R.A., and Bardo M.T. Conditioned increase in place preference by access to novel objects: antagonism by MK-801. Behav Brain Res 99 (1999) 53-60
5. Bevins R.A., and Besheer J. Novelty reward as a measure of anhedonia. Neurosci Biobehav Rev 29 (2005) 707-714
6. Bevins R.A., Besheer J., Palmatier M.I., Jensen H.C., Pickett K.S., and Eurek S. Novel-object place conditioning: behavioral and dopaminergic processes in expression of novelty reward. Behav Brain Res 129 (2002) 41-50
7. Cardinal R.N., Parkinson J.A., Hall J., and Everitt B.J. Emotion and motivation: the role of the amygdala, ventral striatum, and prefrontal cortex. Neurosci Biobehav Rev 26 (2002) 321-352
8. Chen J., Kelz M.B., Hope B.T., Nakabeppu Y., and Nestler E.J. Chronic Fos-related antigens: stable variants of deltaFosB induced in brain by chronic treatments. J Neurosci 17 (1997) 4933-4941
9. Chen J., Nye H.E., Kelz M.B., Hiroi N., Nakabeppu Y., Hope B.T., and Nestler E.J. Regulation of delta FosB and FosB-like proteins by electroconvulsive seizure and cocaine treatments. Mol Pharmacol 48 (1995) 880-889
10. Colby C.R., Whisler K., Steffen C., Nestler E.J., and Self D.W. Striatal cell type-specific overexpression of DeltaFosB enhances incentive for cocaine. J Neurosci 23 (2003) 2488-2493
11. Conversi D., Bonito-Oliva A., Orsini C., and Cabib S. Habituation to the test cage influences amphetamine-induced locomotion and Fos expression and increases FosB/DeltaFosB-like immunoreactivity in mice. Neuroscience 141 (2006) 597-605
12. Di Chiara G. A motivational learning hypothesis of the role of mesolimbic dopamine in compulsive drug use. J Psychopharmacol 12 (1998) 54-67
13. Ehrman R.N., Robbins S.J., Childress A.R., and O'Brien C.P. Conditioned responses to cocaine-related stimuli in cocaine abuse patients. Psychopharmacology 107 (1992) 523-529
14. Gawin F.H. Cocaine addiction: psychology and neurophysiology. Science 251 (1991) 1580-1586
15. Harris G.C., Altomare K., and Aston-Jones G. Preference for a cocaine-associated environment is attenuated by augmented accumbal serotonin in cocaine withdrawn rats. Psychopharmacology 156 (2001) 14-22
16. Harris G.C., and Aston-Jones G. Beta-adrenergic antagonists attenuate withdrawal anxiety in cocaine- and morphine-dependent rats. Psychopharmacology 113 (1993) 131-136
17. Harris G.C., and Aston-Jones G. Augmented accumbal serotonin levels decrease the preference for a morphine associated environment during withdrawal. Neuropsychopharmacology 24 (2001) 75-85
18. Harris G.C., and Aston-Jones G. Altered motivation and learning following opiate withdrawal: evidence for prolonged dysregulation of reward processing. Neuropsychopharmacology 28 (2003) 865-871
19. Harris G.C., and Aston-Jones G. Enhanced morphine preference following prolonged abstinence: Association with increased Fos expression in the extended amygdala. Neuropsychopharmacology 28 (2003) 292-299
20. Harris G.C., and Aston-Jones G. Activation in extended amygdala corresponds to altered hedonic processing during protracted morphine withdrawal. Behav Brain Res 176 (2007) 251-258
21. Hiroi N., Brown J.R., Haile C.N., Ye H., Greenberg M.E., and Nestler E.J. FosB mutant mice: loss of chronic cocaine induction of Fos-related proteins and heightened sensitivity to cocaine's psychomotor and rewarding effects. Proc Natl Acad Sci U S A 94 (1997) 10397-10402
22. Hope B., Kosofsky B., Hyman S.E., and Nestler E.J. Regulation of immediate early gene expression and AP-1 binding in the rat nucleus accumbens by chronic cocaine. Proc Natl Acad Sci U S A 89 (1992) 5764-5768
23. Hope B.T., Kelz M.B., Duman R.S., and Nestler E.J. Chronic electroconvulsive seizure (ECS) treatment results in expression of a long-lasting AP-1 complex in brain with altered composition and characteristics. J Neurosci 14 (1994) 4318-4328
24. Hope B.T., Nye H.E., Kelz M.B., Self D.W., Iadarola M.J., Nakabeppu Y., Duman R.S., and Nestler E.J. Induction of a long-lasting AP-1 complex composed of altered Fos-like proteins in brain by chronic cocaine and other chronic treatments. Neuron 13 (1994) 1235-1244
25. Kelley A.E. Ventral striatal control of appetitive motivation: role in ingestive behavior and reward-related learning. Neurosci Biobehav Rev 27 (2004) 765-776
26. Kelley A.E., Baldo B.A., and Pratt W.E. A proposed hypothalamic-thalamic-striatal axis for the integration of energy balance, arousal, and food reward. J Comp Neurol 493 (2005) 72-85
27. Kelley A.E., and Berridge K.C. The neuroscience of natural rewards: relevance to addictive drugs. J Neurosci 22 (2002) 3306-3311
28. Kelz M.B., Chen J., Carelzon Jr. W.A., Whisler K., Gilden L., Beckmann A.M., Steffen C., Zhang Y.J., Marotti L., Self D.W., Tkatch T., Baranauskas G., Surmeier D.J., Neve R.L., Duman R.S., Picciotto M.R., and Nestler E.J. Expression of the transcription factor deltaFosB in the brain controls sensitivity to cocaine. Nature 401 (1999) 272-276
29. Koob G.F., Ahmed S.H., Boutrel B., Chen S.A., Kenny P.J., Markou A., O'Dell L.E., Parsons L.H., and Sanna P.P. Neurobiological mechanisms in the transition from drug use to drug dependence. Neurosci Biobehav Rev 27 (2004) 739-749
30. Koob G.F., and Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24 (2001) 97-129
31. Kumar A., Choi K.H., Renthal W., Tsankova N.M., Theobald D.E., Truong H.T., Russo S.J., Laplant Q., Sasaki T.S., Whistler K.N., Neve R.L., Self D.W., and Nestler E.J. Chromatin remodeling is a key mechanism underlying cocaine-induced plasticity in striatum. Neuron 48 (2005) 303-314
32. Lee K.W., Kim Y., Kim A.M., Helmin K., Nairn A.C., and Greengard P. Cocaine-induced dendritic spine formation in D1 and D2 dopamine receptor-containing medium spiny neurons in nucleus accumbens. Proc Natl Acad Sci U S A 103 (2006) 3399-3404
33. Lett B.T. Repeated exposures intensify rather than diminish the rewarding effects of amphetamine, morphine, and cocaine. Psychopharmacology 98 (1989) 357-362
34. Louie A.K., Lannon R.A., and Ketter T.A. Treatment of cocaine-induced panic disorder. Am J Psychiatry 146 (1989) 40-44
35. Marttila K., Raattamaa H., and Ahtee L. Effects of chronic nicotine administration and its withdrawal on striatal FosB/DeltaFosB and c-Fos expression in rats and mice. Neuropharmacology 51 (2006) 44-51
36. McClung C.A., and Nestler E.J. Regulation of gene expression and cocaine reward by CREB and DeltaFosB. Nat Neurosci 6 (2003) 1208-1215
37. McClung C.A., Ulery P.G., Perrotti L.I., Zachariou V., Berton O., and Nestler E.J. DeltaFosB: a molecular switch for long-term adaptation in the brain. Brain Res Mol Brain Res 132 (2004) 146-154
38. Moratalla R., Elibol B., Vallejo M., and Graybiel A.M. Network-level changes in expression of inducible Fos-Jun proteins in the striatum during chronic cocaine treatment and withdrawal. Neuron 17 (1996) 147-156
39. Murphy C.A., Russig H., Pezze M.A., Ferger B., and Feldon J. Amphetamine withdrawal modulates FosB expression in mesolimbic dopaminergic target nuclei: effects of different schedules of administration. Neuropharmacology 44 (2003) 926-939
40. Nestler E.J. Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci 2 (2001) 119-128
41. Nestler E.J. Historical review: Molecular and cellular mechanisms of opiate and cocaine addiction. Trends Pharmacol Sci 25 (2004) 210-218
42. Nye H.E., Hope B.T., Kelz M.B., Iadarola M., and Nestler E.J. Pharmacological studies of the regulation of chronic FOS-related antigen induction by cocaine in the striatum and nucleus accumbens. J Pharmacol Exp Ther 275 (1995) 1671-1680
43. Nye H.E., and Nestler E.J. Induction of chronic Fos-related antigens in rat brain by chronic morphine administration. Mol Pharmacol 49 (1996) 636-645
44. Olausson P., Engel J.A., and Soderpalm B. Involvement of serotonin in nicotine dependence: processes relevant to positive and negative regulation of drug intake. Pharmacol Biochem Behav 71 (2002) 757-771
45. Olausson P., Jentsch J.D., Tronson N., Neve R.L., Nestler E.J., and Taylor J.R. DeltaFosB in the nucleus accumbens regulates food-reinforced instrumental behavior and motivation. J Neurosci 26 (2006) 9196-9204
46. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates (1998), Academic Press Inc, San Diego, CA
47. Perrotti L.I., Hadeishi Y., Ulery P.G., Barrot M., Monteggia L., Duman R.S., and Nestler E.J. Induction of deltaFosB in reward-related brain structures after chronic stress. J Neurosci 24 (2004) 10594-10602
48. Pich E.M., Pagliusi S.R., Tessari M., Talabot-Ayer D., Hooft van Huijsduijnen R., and Chiamulera C. Common neural substrates for the addictive properties of nicotine and cocaine. Science 275 (1997) 83-86
49. Rauggi R., Scheggi S., Cassanelli A., De Montis M.G., Tagliamonte A., and Gambarana C. The mesolimbic dopaminergic response to novel palatable food consumption increases dopamine-D1 receptor-mediated signalling with complex modifications of the DARPP-32 phosphorylation pattern. J Neurochem 92 (2005) 867-877
50. Robbins S.J., and Ehrman R.N. Cocaine use is associated with increased craving in outpatient cocaine abusers. Exp Clin Psychopharmacol 6 (1998) 217-224
51. Robbins T.W., and Everitt B.J. Limbic-striatal memory systems and drug addiction. Neurobiol Learn Mem 78 (2002) 625-636
52. Shippenberg T.S., and Heidbreder C. Sensitization to the conditioned rewarding effects of cocaine: pharmacological and temporal characteristics. J Pharmacol Exp Ther 273 (1995) 808-815
53. Vezina P. Sensitization of midbrain dopamine neuron reactivity and the self-administration of psychomotor stimulant drugs. Neurosci Biobehav Rev 27 (2004) 827-839
54. Zachariou V., Bolanos C.A., Selley D.E., Theobald D., Cassidy M.P., Kelz M.B., Shaw-Lutchman T., Berton O., Sim-Selley L.J., Dileone R.J., Kumar A., and Nestler E.J. An essential role for DeltaFosB in the nucleus accumbens in morphine action. Nat Neurosci 9 (2006) 205-211
55. Zhang D., Zhang L., Tang Y., Zhang Q., Lou D., Sharp F.R., Zhang J., and Xu M. Repeated cocaine administration induces gene expression changes through the dopamine D1 receptors. Neuropsychopharmacology 30 (2005) 1443-1454
56. Zhang J., and Xu M. Opposite regulation of cocaine-induced intracellular signaling and gene expression by dopamine D1 and D3 receptors. Ann N Y Acad Sci 1074 (2006) 1-12
57. Zhang J., Zhang D., and Xu M. Identification of chronic cocaine-induced gene expression through dopamine d1 receptors by using cDNA microarrays. Ann N Y Acad Sci 965 (2002) 1-9